Riccardo Maragna

Riccardo Maragna

Auto-generated profile, based on publicly available information

Riccardo Maragna

Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS , Milan 20134

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in JACC
Verified
Journal Article
Closed access
Andrea MazzantiAndrea Mazzanti
Andrea Mazzanti
RMRiccardo Maragna
Riccardo Maragna
AFAlessandro Faragli
Alessandro Faragli
NMNicola Monteforte
Nicola Monteforte
RBRaffaella Bloise
Raffaella Bloise
SPSilvia G. Priori
Silvia G. Priori

1 April 2018 in JACC
Verified
Journal Article
Closed access
Andrea MazzantiAndrea Mazzanti
Andrea Mazzanti
RMRiccardo Maragna
Riccardo Maragna
GVGaetano Vacanti
Gaetano Vacanti
NMNicola Monteforte
Nicola Monteforte
RBRaffaella Bloise
Raffaella Bloise
SPSilvia G. Priori
Silvia G. Priori

1 December 2016 in JACC
Verified
Journal Article
Closed access
Andrea MazzantiAndrea Mazzanti
Andrea Mazzanti
KNKevin Ng
Kevin Ng
AFAlessandro Faragli
Alessandro Faragli
RMRiccardo Maragna
Riccardo Maragna
ECElena Chiodaroli
Elena Chiodaroli
SPSilvia G. Priori
Silvia G. Priori

1 December 2017 in JACC
Verified
Journal Article
Closed access
Andrea MazzantiAndrea Mazzanti
Andrea Mazzanti
RMRiccardo Maragna
Riccardo Maragna
GVGaetano Vacanti
Gaetano Vacanti
AKAnna Kostopoulou
Anna Kostopoulou
MMMaira Marino
Maira Marino
SPSilvia G. Priori
Silvia G. Priori

7 March 2021 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
Massimo MapelliMassimo Mapelli
Massimo Mapelli
ESElisabetta Salvioni
Elisabetta Salvioni
FMFabiana De Martino
Fabiana De Martino
IMIrene Mattavelli
Irene Mattavelli
PGPaola Gugliandolo
Paola Gugliandolo
PAPiergiuseppe Agostoni
Piergiuseppe Agostoni
During the COVID-19 pandemic, the use of protective masks has been essential to reduce contagions. However, public opinion is that there is an associated subjective shortness of breath. We evaluated cardiorespiratory parameters at rest and during maximal exertion to highlight any differences with the use of protective masks.12 healthy subjects performed three identical cardiopulmonary exercise tests, one without wearing a protective mask, one wearing a surgical mask and one with a filtering face piece particles class 2 (FFP2) mask. Dyspnoea was assessed using the Borg scale. Standard pulmonary function tests were also performed.All the subjects (40.8±12.4 years; six male) completed the protocol with no adverse events. Spirometry showed a progressive reduction of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) from no mask to surgical to FFP2 (FEV1: 3.94±0.91 L, 3.23±0.81 L, 2.94±0.98 L; FVC: 4.70±1.21 L, 3.77±1.02 L, 3.52±1.21 L; p<0.001). Rest ventilation, O2uptake (V˙O2) and CO2production (V˙CO2) were progressively lower, with a reduction in respiratory rate. At peak exercise, subjects had a progressively higher Borg scale when wearing surgical and FFP2 masks. Accordingly, at peak exercise,V˙O2(31.0±23.4 mL·kg−1·min−1, 27.5±6.9 mL·kg−1·min−1, 28.2±8.8 mL·kg−1·min−1; p=0.001), ventilation (92±26 L, 76±22 L, 72±21 L; p=0.003), respiratory rate (42±8 breaths·min−1, 38±5 breaths·min−1, 37±4 breaths·min−1; p=0.04) and tidal volume (2.28±0.72 L, 2.05±0.60 L, 1.96±0.65 L; p=0.001) were gradually lower. There was no significant difference in oxygen saturation.Protective masks are associated with significant but modest worsening of spirometry and cardiorespiratory parameters at rest and peak exercise. The effect is driven by a ventilation reduction due to increased airflow resistance. However, because exercise ventilatory limitation is far from being reached, their use is safe even during maximal exercise, with a slight reduction in performance.

23 January 2024 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
GNGuido Nannini
Guido Nannini
SSSimone Saitta
Simone Saitta
Andrea BaggianoAndrea Baggiano
Andrea Baggiano
RMRiccardo Maragna
Riccardo Maragna
SMSaima Mushtaq
Saima Mushtaq
ARAlberto Redaelli
Alberto Redaelli
Coronary computed tomography angiography (CCTA) allows detailed assessment of early markers associated with coronary artery disease (CAD), such as coronary artery calcium (CAC) and tortuosity (CorT). However, their analysis can be time-demanding and biased. We present a fully automated pipeline that performs (i) coronary artery segmentation and (ii) CAC and CorT objective analysis. Our method exploits supervised learning for the segmentation of the lumen, and then, CAC and CorT are automatically quantified. 281 manually annotated CCTA images were used to train a two-stage U-Net-based architecture. The first stage employed a 2.5D U-Net trained on axial, coronal, and sagittal slices for preliminary segmentation, while the second stage utilized a multichannel 3D U-Net for refinement. Then, a geometric post-processing was implemented: vessel centerlines were extracted, and tortuosity score was quantified as the count of branches with three or more bends with change in direction forming an angle >45°. CAC scoring relied on image attenuation. CAC was detected by setting a patient specific threshold, then a region growing algorithm was applied for refinement. The application of the complete pipeline required <5 min per patient. The model trained for coronary segmentation yielded a Dice score of 0.896 and a mean surface distance of 1.027 mm compared to the reference ground truth. Tracts that presented stenosis were correctly segmented. The vessel tortuosity significantly increased locally, moving from proximal, to distal regions (p < 0.001). Calcium volume score exhibited an opposite trend (p < 0.001), with larger plaques in the proximal regions. Volume score was lower in patients with a higher tortuosity score (p < 0.001). Our results suggest a linked negative correlation between tortuosity and calcific plaque formation. We implemented a fast and objective tool, suitable for population studies, that can help clinician in the quantification of CAC and various coronary morphological parameters, which is helpful for CAD risk assessment.